ML-7 amplifies the quinocetone-induced cell death through akt and MAPK-mediated apoptosis on HepG2 cell line

References

• Altomare DA, Testa JR. (2005). Perturbations of the AKT signaling pathway in human cancer. Oncogene 24:7455–64
   PubMed Web of Science ®Google Scholar
• Bai L, Wang S. (2014). Targeting apoptosis pathways for new cancer therapeutics. Annu Rev Med 65:139–55
   PubMed Web of Science ®Google Scholar
• Bradham C, McClay DR. (2006). p38 MAPK in development and cancer. Cell Cycle 5:824–8
   PubMed Web of Science ®Google Scholar
• Burotto M, Chiou VL, Lee JM, Kohn EC. (2014). The MAPK pathway across different malignancies: a new perspective. Cancer 120:3446–56
   PubMed Web of Science ®Google Scholar
• Chang F, Lee JT, Navolanic PM, et al. (2003). Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy. Leukemia 17:590–603
   PubMed Web of Science ®Google Scholar
• Chen Q, Tang S, Jin X, et al. (2009). Investigation of the genotoxicity of quinocetone, carbadox and olaquindox in vitro using Vero cells. Food Chem Toxicol 47:328–34
   PubMed Web of Science ®Google Scholar
• Cui WJ, Liu Y, Zhou XL, et al. (2010). Myosin light chain kinase is responsible for high proliferative ability of breast cancer cells via anti-apoptosis involving p38 pathway. Acta Pharmacol Sin 31:725–32
   PubMed Web of Science ®Google Scholar
• Dent P, Yacoub A, Fisher PB, et al. (2003). MAPK pathways in radiation responses. Oncogene 22:5885–96
   PubMed Web of Science ®Google Scholar
• Eferl R, Ricci R, Kenner L, et al. (2003). Liver tumor development. c-Jun antagonizes the proapoptotic activity of p53. Cell 112:181–92
   PubMed Web of Science ®Google Scholar
• Fazal F, Gu L, Ihnatovych I, et al. (2005). Inhibiting myosin light chain kinase induces apoptosis in vitro and in vivo. Mol Cell Biol 25:6259–66
   PubMed Web of Science ®Google Scholar
• Fenteany G, Zhu ST. (2003). Small-molecule inhibitors of actin dynamics and cell motility. Curr Topics Med Chem 3:593–616
   PubMed Web of Science ®Google Scholar
• Fesik SW. (2005). Promoting apoptosis as a strategy for cancer drug discovery. Nat Rev Cancer 5:876–85
   PubMed Web of Science ®Google Scholar
• Franke TF, Hornik CP, Segev L, et al. (2003). PI3K/Akt and apoptosis: size matters. Oncogene 22:8983–98
   PubMed Web of Science ®Google Scholar
• Gourlay CW, Ayscough KR. (2006). Actin-induced hyperactivation of the Ras signaling pathway leads to apoptosis in Saccharomyces cerevisiae. Mol Cell Biol 26:6487–501
   PubMed Web of Science ®Google Scholar
• Gu LZ, Hu WY, Antic N, et al. (2006). Inhibiting myosin light chain kinase retards the growth of mammary and prostate cancer cells. Eur J Cancer 42:948–57
   PubMed Web of Science ®Google Scholar
• Hay N. (2005). The Akt-mTOR tango and its relevance to cancer. Cancer Cell 8:179–83
   PubMed Web of Science ®Google Scholar
• Hennessy BT, Smith DL, Ram PT, et al. (2005). Exploiting the PI3K/AKT pathway for cancer drug discovery. Nat Rev Drug Discov 4:988–1004
   PubMed Web of Science ®Google Scholar
• Huang XL, Cui GH, Zhou KY. (2008). Correlation of PI3K-Akt signal pathway to apoptosis of tumor cells. Chinese J Cancer 27:331–6
   Google Scholar
• Ihsan A, Wang X, Zhang W, et al. (2013). Genotoxicity of quinocetone, cyadox and olaquindox in vitro and in vivo. Food Chem Toxicol 59:207–14
   PubMed Web of Science ®Google Scholar
• Jana SS, Kawamoto S, Adelstein RS. (2006). A specific isoform of nonmuscle myosin II-C is required for cytokinesis in a tumor cell line. J Biol Chem 281:24662–70
   PubMed Web of Science ®Google Scholar
• Jin X, Chen Q, Tang SS, et al. (2009). Investigation of quinocetone-induced genotoxicity in HepG2 cells using the comet assay, cytokinesis-block micronucleus test and RAPD analysis. Toxicol In Vitro 23:1209–14
   PubMed Web of Science ®Google Scholar
• Jordan MA, Wilson L. (1998). Microtubules and actin filaments: dynamic targets for cancer chemotherapy. Curr Opin Cell Biol 10:123–30
   PubMed Web of Science ®Google Scholar
• Jordan MA, Wilson L. (2004). Microtubules as a target for anticancer drugs. Nat Rev Cancer 4:253–65
   PubMed Web of Science ®Google Scholar
• Kataoka K, Matsumoto H, Kaneko H, et al. (2015). Macrophage- and RIP3-dependent inflammasome activation exacerbates retinal detachment-induced photoreceptor cell death. Cell Death Dis 6:e1731
   PubMed Web of Science ®Google Scholar
• Knasmuller S, Mersch-Sundermann V, Kevekordes S, et al. (2004). Use of human-derived liver cell lines for the detection of environmental and dietary genotoxicants; current state of knowledge. Toxicology 198:315–28
   PubMed Web of Science ®Google Scholar
• Knauf JA, Fagin JA. (2009). Role of MAPK pathway oncoproteins in thyroid cancer pathogenesis and as drug targets. Curr Opin Cell Biol 21:296–303
   PubMed Web of Science ®Google Scholar
• Kondratskyi A, Yassine M, Slomianny C, et al. (2014). Identification of ML-9 as a lysosomotropic agent targeting autophagy and cell death. Cell Death Dis 5:e1193
   PubMed Web of Science ®Google Scholar
• Lee JW, Ha TK, Woo HD, Chung HW. (2009). Cytotoxic effects of myosin light chain kinase inhibitor Ml-7 alone and in combination with flavonoid against Hl-60. Ann Oncol 20:33
   Web of Science ®Google Scholar
• Li Q, Chen M, Liu HM, et al. (2014). The dual role of ERK signaling in the apoptosis of neurons. Front Biosci 19:1411–17
   PubMed Web of Science ®Google Scholar
• Llovet JM, Burroughs A, Bruix J. (2003). Hepatocellular carcinoma. Lancet 362:1907–17
   PubMed Web of Science ®Google Scholar
• Manning BD, Cantley LC. (2007). AKT/PKB signaling: navigating downstream. Cell 129:1261–74
   PubMed Web of Science ®Google Scholar
• New DC, Wu K, Kwok AWS, Wong YH. (2007). G protein-coupled receptor-induced Akt activity in cellular proliferation and apoptosis. FEBS J 274:6025–36
   PubMed Web of Science ®Google Scholar
• Rane MJ, Klein JB. (2009). Regulation of neutrophil apoptosis by modulation of PKB/Akt activation. Front Biosci 14:2400–12
   Web of Science ®Google Scholar
• Roux PP, Blenis J. (2004). ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol Mol Biol Rev 68:320–44
   PubMed Web of Science ®Google Scholar
• Sinpitaksakul SN, Pimkhaokham A, Sanchavanakit N, Pavasant P. (2008). TGF-beta1 induced MMP-9 expression in HNSCC cell lines via Smad/MLCK pathway. Biochem Biophys Res Commun 371:713–18
   PubMed Web of Science ®Google Scholar
• Strasser A, O’Connor L, Dixit VM. (2000). Apoptosis signaling. Annu Rev Biochem 69:217–45
   PubMed Web of Science ®Google Scholar
• Sui X, Kong N, Ye L, et al. (2014). p38 and JNK MAPK pathways control the balance of apoptosis and autophagy in response to chemotherapeutic agents. Cancer Lett 344:174–9
   PubMed Web of Science ®Google Scholar
• Vivanco I, Sawyers CL. (2002). The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat Rev Cancer 2:489–501
   PubMed Web of Science ®Google Scholar
• Wada T, Penninger JM. (2004). Mitogen-activated protein kinases in apoptosis regulation. Oncogene 23:2838–49
   PubMed Web of Science ®Google Scholar
• Wagner EF, Nebreda AR. (2009). Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer 9:537–49
   PubMed Web of Science ®Google Scholar
• Wang D, Zhong Y, Luo XA, et al. (2011). Pu-erh black tea supplementation decreases quinocetone-induced ROS generation and oxidative DNA damage in Balb/c mice. Food Chem Toxicol 49:477–84
   PubMed Web of Science ®Google Scholar
• Wang X, Zhang W, Wang YL, et al. (2010). Acute and sub-chronic oral toxicological evaluations of quinocetone in Wistar rats. Regul Toxicol Pharmacol 58:421–7
   PubMed Web of Science ®Google Scholar
• Watanabe T, Nakagawa K, Ohata S, et al. (2002). SEK1/MKK4-mediated SAPK/JNK signaling participates in embryonic hepatoblast proliferation via a pathway different from NF-kappaB-induced anti-apoptosis. Dev Biol 250:332–47
   PubMed Web of Science ®Google Scholar
• Yang W, Fu J, Xiao X, et al. (2013). Quinocetone triggers oxidative stress and induces cytotoxicity and genotoxicity in human peripheral lymphocytes of both genders. J Sci Food Agric 93:1317–25
   PubMed Web of Science ®Google Scholar
• Yu M, Wang D, Xu M, et al. (2014). Quinocetone-induced Nrf2/HO-1 pathway suppression aggravates hepatocyte damage of Sprague-Dawley rats. Food Chem Toxicol 69:210–19
   PubMed Web of Science ®Google Scholar
• Yu M, Xu M, Liu Y, et al. (2013). Nrf2/ARE is the potential pathway to protect Sprague-Dawley rats against oxidative stress induced by quinocetone. Regul Toxicol Pharmacol 66:279–85
   PubMed Web of Science ®Google Scholar
• Zhang C, Wang C, Tang S, et al. (2013). TNFR1/TNF-α and mitochondria interrelated signaling pathway mediates quinocetone-induced apoptosis in HepG2 cell. Food Chem Toxicol 62:825–38
   PubMed Web of Science ®Google Scholar
• Zhang W, Liu HT. (2002). MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell Res 12:9–18
   PubMed Web of Science ®Google Scholar
• Zhang XB, Tang NM, Hadden TJ, Rishi AK. (2011). Akt, FoxO and regulation of apoptosis. Biochim Biophys Acta 1813:1978–86
   PubMed Web of Science ®Google Scholar
• Zhong JL, Zhang GJ, Shen XG, et al. (2011). Pharmacokinetics of quinocetone and its major metabolites in swine after intravenous and oral administration. Agric Sci China 10:1292–300
   Web of Science ®Google Scholar
• Zhou XL, Liu Y, You JC, et al. (2008). Myosin light-chain kinase contributes to the proliferation and migration of breast cancer cells through cross-talk with activated ERK1/2. Cancer Lett 270:312–27
   PubMed Web of Science ®Google Scholar